Biomarin Pharmaceutical Inc
2013 Q4 - 2025 Q3 (27 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q3 | 10/24/2025 | 1,104 | 0.0% | 20,387 | 9/30/2025 |
| 2025 Q2 | 7/10/2025 | 1,121 | 0.0% | 20,387 | 6/30/2025 |
| 2025 Q1 | 4/28/2025 | 1,459 | 0.0% | 20,643 | 3/31/2025 |
| 2024 Q4 | 1/28/2025 | 1,365 | 0.0% | 20,763 | 12/31/2024 |
| 2024 Q3 | 10/17/2024 | 1,459 | 0.0% | 20,763 | 9/30/2024 |
| 2024 Q2 | 7/30/2024 | 1,385 | 0.0% | 16,824 | 6/30/2024 |
| 2024 Q1 | 5/2/2024 | 1,459 | 0.0% | 16,707 | 3/31/2024 |
| 2023 Q4 | 2/1/2024 | 1,616 | 0.0% | 16,761 | 12/31/2023 |
| 2023 Q3 | 10/30/2023 | 1,477 | 0.0% | 16,688 | 9/30/2023 |
| 2023 Q2 | 8/4/2023 | 1,450 | 0.0% | 16,729 | 6/30/2023 |
| 2023 Q1 | 5/2/2023 | 1,629 | 0.0% | 16,748 | 3/31/2023 |
| 2022 Q4 | 1/26/2023 | 1,498 | 0.0% | 14,473 | 12/31/2022 |
| 2022 Q3 | 10/19/2022 | 1,227 | 0.0% | 14,473 | 9/30/2022 |
| 2022 Q2 | 7/13/2022 | 1,190 | 0.0% | 14,356 | 6/30/2022 |
| 2022 Q1 | 4/19/2022 | 908 | 0.0% | 11,772 | 3/31/2022 |
| 2021 Q4 | 1/20/2022 | 1,048 | 0.0% | 11,871 | 12/31/2021 |
| 2021 Q3 | 10/15/2021 | 746 | 0.0% | 9,653 | 9/30/2021 |
| 2021 Q2 | 7/19/2021 | 810 | 0.0% | 9,718 | 6/30/2021 |
| 2021 Q1 | 5/7/2021 | 733 | 0.0% | 9,718 | 3/31/2021 |
| 2020 Q4 | 2/2/2021 | 852 | 0.0% | 9,718 | 12/31/2020 |
| 2020 Q3 | 10/29/2020 | 739 | 0.0% | 9,718 | 9/30/2020 |
| 2020 Q2 | 8/12/2020 | 1,204 | 0.0% | 9,763 | 6/30/2020 |
| 2020 Q1 | 4/21/2020 | 823 | 0.0% | 9,748 | 3/31/2020 |
| 2019 Q4 | 1/24/2020 | 818 | 0.0% | 9,678 | 12/31/2019 |
| 2014 Q2 | 7/14/2014 | 1,756 | 0.1% | 28,229 | 6/30/2014 |
| 2014 Q1 | 4/16/2014 | 2,123 | 0.1% | 31,129 | 3/31/2014 |
| 2013 Q4 | 1/22/2014 | 1,136 | 0.0% | 16,170 | 12/31/2013 |